Effect of 26 week magnetic field exposures in a DMBA initiation-promotion mammary gland model in Sprague-Dawley rats

Carcinogenesis

Volumn 20, Issue 5, 1999, Pages 899-904

  Boorman, Gary A ^a   Anderson, Larry E ^b   Morris, James E ^b   Sasser, Lyle B ^b   Mann, Peter C ^c   Grumbein, Sondra L ^b   Hailey, James R ^a   McNally, Alan ^c   Sills, Robert C ^a   Haseman, Joseph K ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INCIDENCE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; FEMALE; FIBROADENOMA; HISTOPATHOLOGY; MAGNETIC FIELD; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR PROMOTION;

EID: 0032902831     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.5.899     Document Type: Article

References (26)

1. Miller,F.J. and Schroeer,D. (1987) College Physics. 6th edn. Harcourt Brace Jananovich, San Diego, CA.
2. Theriault,G., Goldberg,M., Miller,A.B., Armstrong,B., Guenel P., Deadman,J., Imbernon,E., To,T., Chevalier,A., Cyr,D. and Wall,C. (1994) Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970-1989. Am. J. Epidemiol., 139, 550-572.
3. Matanoski,G.M, Breyese,P.N. and Elliot,E.A. (1991) Electromagnetic field exposure and male breast cancer. Lancet, 33, 737.
4. Tynes,T. (1993) Electromagnetic fields and male breast cancer. Biomed. Pharmacother., 47, 425-427.
5. Loomis,D.P., Savitz,D.A. and Ananth,C.V. (1994) Breast cancer mortality among female electrical workers in the United States. J. Natl Cancer Inst., 86, 921-925.
6. Stevens,R.G. (1987) Electric power use and breast cancer: a hypothesis. Am. J. Epidemiol., 125, 556-561.
7. Mandeville,R., Franco,E., Sidrac-Ghali,S., Paris-Nadon,L., Rocheleau,N., Mercier,G., Desy,M. and Gaboury,L. (1997) Evaluation of the potential carcinogenicity of 60 Hz linear sinusoidal continuous-wave magnetic fields in Fischer F344 rats. FASEB J., 11, 1127-1136.
8. Yasui,M., Kikuchi,T., Ogawa,M., Otaka,Y., Tsuchitani,M. and Iwata,H. (1997) Carcinogenicity test of 50 Hz sinusoidal magnetic fields in rats. Bioelectromagnetics, 18, 531-540.
9. National Toxicology Program (1997) Toxicity and carcinogenicity studies of 60-Hz magnetic fields administered by whole body exposure to F344/N rats and B6C3F1 mice. NTP TR 488, NIH publication no. 98-3978. US Dept of Health and Human Services, NC.
10. Baum,A., Mevissen,M., Kamino,K., Mohr,U. and Löscher,W. (1995) A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 μT magnetic field exposure. Carcinogenesis, 16, 119-125.
11. Löscher,W., Mevissen,M., Lehmacher,W. and Stamm,A. (1993) Tumor promotion in a breast cancer model by exposure to a weak alternating magnetic field. Cancer Lett., 71, 75-81.
12. Löscher,W. and Mevissen,M. (1994) Animal studies on the role of 50/60-Hertz magnetic fields in carcinogenesis. Life Sci., 54, 1531-1543.
13. Löscher,W., Wahnschaffe,U., Mevissen,M., Lerchl,A. and Stamm,A. (1994) Effects of weak alternating magnetic fields on nocturnal melatonin production and mammary carcinogenesis in rats. Oncology, 51, 288-295.
14. Mevissen,M., Stamm,A., Buntenkotter,S., Zwingelberg,R., Wahnschaffe,U. and Löscher,W. (1993) Effects of magnetic fields on mammary tumor development induced by 7,12-dimethylbenz(a)anthracene in rats. Bioelectromagnetics, 14, 131-143.
15. Mevissen,M., Buntenkotter,S. and Löscher,W. (1994) Effects of static and time-varying (50-Hz) magnetic fields on reproduction and fetal development in rats. Teratology, 50, 229-237.
16. Mevissen,M., Kietzmann,M. and Löscher,W. (1995) In vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBA. Cancer Lett., 90, 207-214.
17. Aylsworth,C.F., Jones,C., Trosko,J.E., Meites,J. and Welsch,C.W. (1984) Promotion of 7,12-dimethylbenz[a]antrracene-induced mammary tumorigenesis by high dietary fat in the rat: Possible role of intercellular communication. J. Natl Cancer Inst., 72, 637-645.
18. Hirose,M., Hoshiya,T., Akagi,K., Futakuchi,M. and Ito,N. (1994) Inhibition of mammary carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[a]anthracene. Cancer Lett., 83, 149-156.
19. Russo,J., Gusterson,B.A., Rogers,A.E., Russo,J.H., Wellings,S.R. and van Zweiten,M.J. (1990) Comparative study of human and rat mammary tumorigenesis. Lab. Invest., 62, 244-278.
20. Bailer,A.J. and Portier,C.J. (1988) Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics, 44, 417-431.
21. Portier,C.J. and Bailer,A.J. (1989) Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam. Appl. Toxicol., 12, 731-737.
22. Piergorsch,W.W. and Bailer,A.J. (1997) Statistic for Environmental Biology and Toxicology. Chapman and Hall, London, UK.
23. Dunnett,C.W. (1955) A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc., 50, 1096-1121.
24. Ekstrom,T., Mild,K.H. and Holmberg,B. (1998) Mammary tumours in Sprague-Dawley rats after initiation with DMBA followed by exposure to 50 Hz electromagnetic fields in a promotional scheme. Cancer Lett., 123, 107-111.
25. Mevissen,M., Haubler,M., Lerchl,A. and Löscher,W. (1998) Acceleration of mammary tumorigenesis by exposure to 7,12-dimethylbenz(a)anthacene-treated female rats in a 50-Hz 100-μT magnetic field: replication study. J. Toxicol. Environ. Health, 53, 401-418.
26. Mevissen,M., Lerchl,A., Szamel,M. and Löscher,W. (1996) Exposure of DMBA-treated female rats in a 50-Hz 50-μT magnetic field: effects on mammary tumor growth, melatonin levels, and T lymphocyte activation. Carcinogenesis, 17, 903-910.